Rémy Cointreau lifts guidance after U.S.-EU tariff cut on spirits

Rémy Cointreau (RCOP) has raised its fiscal 2026 operating profit guidance to a mid-single-digit decline, improving from a prior mid- to high-single-digit forecast, after a US/EU agreement halved tariffs on European spirits to 15%. This tariff reduction is expected to mitigate the earnings hit by €15 million, with half being reinvested into growth, leading Jefferies to reiterate a 'buy' rating and a €70 price target, signaling a potential bottoming of the company's cognac business.

Analysis

Rémy Cointreau (RCOP) has upgraded its fiscal 2026 operating profit guidance following a favorable US/EU trade agreement that halved planned tariffs on European spirits to 15%. This revision reduces the anticipated negative earnings impact from €45 million to €30 million. The resulting €15 million relief, which represents approximately 8% of Jefferies' fiscal 2026 EBIT forecast of €190 million, has prompted the company to narrow its guidance to a mid-single-digit profit decline from a prior forecast of mid- to high-single-digits. Notably, management is reinvesting half of this benefit into growth initiatives in the US and China. While consensus estimates for fiscal 2026—projecting a 3.5% organic sales growth and a 4.1% EBIT decline—remain unchanged for now, the updated guidance aligns with these expectations. Analyst commentary from Jefferies is positive, reiterating a 'buy' rating and a €70 price target, which implies a 28% upside from the recent close. Their view is that while visibility on the recovery's timing is low, tail risks are abating and the core cognac business appears to be bottoming out.

Key Decisions for Investors

• The improved FY26 guidance, driven by a tangible €15 million earnings benefit from tariff relief, de-risks the financial outlook and strengthens the investment thesis that the company's performance is stabilizing.
• Investors should monitor the execution and return on the €7.5 million being reinvested in the US and China, as success in these markets is critical to validating the medium-term recovery narrative.
• Given the 28% upside to Jefferies' price target and the abatement of regulatory tail risk, the current share price may represent an attractive entry point, particularly as broader market consensus has not yet been revised upwards to reflect this positive development.